18F-DOPA, a Clinically Available PET Tracer to Study Brain Inflammation?

Heiss, 1996, F-Dopa as an amino acid tracer to detect brain tumors., J Nucl Med, 37, 1180

Tripathi, 2009, Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PETCT for metabolic imaging of low grade gliomas., Clin Nucl Med, 34, 878, 10.1097/RLU.0b013e3181becfe0

Nioche, 2013, Evaluation of quantitative criteria for glioma grading with static and dynamic 18F-FDopa PETCT., Clin Nucl Med, 38, 81, 10.1097/RLU.0b013e318279fd5a

Karunanithi, 2013, Prospective comparison of 99mTc-GH SPECTCT and 18F-FDOPA PETCT for detection of recurrent glioma: a pilot study., Clin Nucl Med, 39, e121, 10.1097/RLU.0b013e318279bcd8

Alper, 2012, Acute disseminated encephalomyelitis., J Child Neurol, 27, 1408, 10.1177/0883073812455104

Haase, 2007, L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo., J Nucl Med, 48, 2063, 10.2967/jnumed.107.043620

Nozaki, 2013, Neurosarcoidosis., Curr Treat Options Neurol, 15, 492, 10.1007/s11940-013-0242-9

Kim, 2010, F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomographycomputed tomography imaging in a case of neurosarcoidosis., Clin Nucl Med, 35, 67, 10.1097/RLU.0b013e3181c7c149